Gitnux/Report 2026

Medical Endoscopy Industry Statistics

The global medical endoscopy market is estimated at $33.1 billion in 2026, explore the figures behind growth, companies and trends.
45Statistics
43Sources
10Sections
1Visuals
19mRead
November 20, 2026Updated
Medical Endoscopy Industry Statistics
How this report is researched
01Editorial Scope

Before any source is gathered, an editor locks the question, what qualifies, and how the piece will be judged.

02Source Research

Search agents collect the source set and pull each data point out with its provenance attached.

Read our full methodology →

Search agents attach provenance to every extracted figure.

Next review: within 28 days

01 Industry overview

The medical endoscopy industry at a glance

The global medical endoscopy market is estimated at $33.1 billion in 2026, with growth supported by minimally invasive care, chronic disease prevalence and rapid adoption of single-use systems.

$33.1B[24]
Global market size, 2026
7.1%[24]
Forecast CAGR, 2026–2035
45%[24]
Top five share, 2025
23.5M[4]
U.S. procedures, 2022
Market size
The global endoscopy market was estimated at $31.2 billion in 2025 and $33.1 billion in 2026. The U.S. market reached $10.9 billion in 2025, representing approximately one-third of the global market.[24]
Forecast & CAGR
The global market is forecast to reach $61.5 billion by 2035, implying a 7.1% CAGR from 2026 to 2035. The endoscopes product segment is projected to grow at a 7.4% CAGR over the same period.[24]
Market share & regions
North America was identified as the largest regional market in 2025, while Asia Pacific was forecast to be the fastest-growing region. Ambu reported that North America accounted for 50% of its 2024/25 revenue, Europe 40% and the rest of the world 10%.[24][25]
Segmentation
By product, endoscopes accounted for 49.4% of the global market in 2025. The market is segmented into endoscopes, visualization systems, endoscopic ultrasound systems, insufflators and other products, with applications spanning gastrointestinal, respiratory, urological and ENT procedures.[24]
Key players & concentration
Olympus led the global market with more than 15% share in 2025. The five leading companies—Boston Scientific, Stryker, Olympus, Karl Storz and Medtronic—collectively held 45% of the market.[24]
Pricing
Single-use products are increasingly competing on total procedure economics rather than purchase price alone. Ambu reported a 13% lower cost for single-use bronchoscopes than reusable alternatives and a 20% lower carbon footprint for single-use cystoscopes in the cited studies.[25]
Trends, drivers & challenges
Demand is being driven by aging populations, chronic and gastrointestinal disease, minimally invasive surgery, advanced visualization, AI and data analytics. Single-use endoscopy is expected to grow by more than 20% annually from 2025 to 2030, while shortages of skilled physicians and endoscopists remain a constraint in developing countries.[24][25]
Consumer behavior & competition
U.S. utilization remains concentrated in colonoscopy and upper endoscopy: estimated 2022 volumes were 15.5 million colonoscopies and 7.2 million upper endoscopies, out of 23.5 million total listed procedures. Competition is shifting toward integrated visualization, reporting, connectivity, AI and disposable platforms.[4][26]
M&A
Boston Scientific agreed in March 2026 to acquire the remaining 99% of Scivita Medical for $200 million upfront plus up to $30 million in milestone payments; the transaction was expected to close in the third quarter of 2026. In September 2026, Ambu acquired TIMS Medical for $45 million upfront and up to $20 million in milestones, adding about 7,000 U.S. hospital installations.[27][26]
Regulation
In the United States, endoscopes and accessories are generally Class II devices under regulation 21 CFR 876.1500 and commonly follow the 510(k) pathway. FDA guidance requires reprocessing validation data for relevant reusable endoscopes, while FDA continues to recommend designs and procedures that reduce duodenoscope reprocessing infection risks.[28][29]
Latest news
The latest identified industry transaction is Ambu’s September 14, 2026 acquisition of TIMS Medical, a U.S. imaging and reporting technology company. Ambu said TIMS contributed approximately $15 million in annual revenue and expanded its reach to around 7,000 U.S. hospital installations.[26]

02 Ranking

Top 10 Companies in the Medical Endoscopy Industry

The leading companies in the medical endoscopy industry, ranked on market impact, performance, momentum, innovation and brand popularity.

Updated November 20, 2026 · Next review December 20, 2026

Verdict

Boston Scientific stands out for GI, urology and therapeutic endoscopy devices because it reported $2.916 billion in 2025 endoscopy sales, while HOYA focuses on PENTAX-branded medical endoscopes since it provides medical endoscopes under the PENTAX brand.

Ranked by Overall score · How we score ↓

Editor's top 3 picks

Where to start, by need.

  1. #1 Overall · Leader in endoscopy devices

    Boston Scientific

    US

    Ranked #1 · 9.6 · Endoscopy devices

    Why we picked it: Its GI, urology and therapeutic endoscopy portfolio matches the GI-heavy procedure volumes tracked in the U.S.

  2. #2 overall

    HOYA

    JP

    Ranked #2 · 9.2 · Endoscopy devices

    Why we picked it: Its PENTAX GI endoscopy systems positioning aligns with the market’s endoscopes-heavy 2025 share.

  3. #3 overall

    Stryker

    US

    Ranked #3 · 8.9 · Endoscopy devices

    Why we picked it: Its surgical visualization and minimally invasive endoscopy systems align with integrated workflow adoption.

Pick 1 is the #1 company overall. No other segment places in the top 5, so picks 2 and 3 follow rank.

Full ranking

Sort by
Top 10 companies in the medical endoscopy industry, 2026 – Gitnux ranking
#CompanyOverall ↓Company snapshot
1

Boston Scientific

Endoscopy devices · US

9.6
2

HOYA

Endoscopy devices · JP

9.2
3

Stryker

Endoscopy devices · US

8.9
4

FUJIFILM Holdings

Endoscopy devices · JP

8.9
5

Medtronic

Endoscopy devices · IE

8.9
6

Olympus

GI, surgical, respiratory and urology endoscopy · JP

8.7
7

KARL STORZ

Rigid endoscopy and operating-room systems · DE

8.4
8

STERIS

GI endoscopy devices and endoscope care · US

8.3
9

Richard Wolf

Rigid endoscopy and minimally invasive surgery · DE

8.1
10

CONMED

Laparoscopic, GI and surgical endoscopy devices · US

7.6

How we score

  • Impact (30%): scale and weight in the market (revenue, market share, employees, market position).
  • Performance (20%): recent revenue growth and operating margin; an analyst assessment where a company does not publish them.
  • Momentum (20%): growth trajectory and future potential.
  • Innovation (15%): R&D intensity and how technologically advanced the company is.

Popularity (brand search demand, 15%) counts toward Overall but is not published as a column. Overall leaves out what is not known.

Scale Scores are shown on a 7–10 scale with one decimal; bars start at 7.0.

Cadence Recalculated when new figures are published; next review December 20, 2026.

Independence. Rankings are editorially independent. Scores, ranks, picks and the verdict follow the method above; no company can pay to change them.

Cite this ranking

APA

Elena Vasquez. (2026, February 13). Top 10 companies in the medical endoscopy industry. In Medical Endoscopy Industry Statistics. Gitnux. https://gitnux.org/medical-endoscopy-industry-statistics/#top-companies

report visual · Comparison

Revenue of the largest medical endoscopy companies

Medtronic leads with $36.4B in annual revenue (group level, converted to USD).

Medtronic$36.4B
Stryker$25.1B
FUJIFILM Holdings$22.5B
Boston Scientific$20.1B
Olympus$6.8B
HOYA$6.3B
source-verifiedinvestorrelations.medtronic.com · careers.stryker.com · holdings.fujifilm.com · investors.bostonscientific.com · olympus-global.com · hoya.com2026

04 Statistics

Technology & AI

Endoscopist survey results in 2026 show reimbursement as a key AI adoption factor, with 71.9% of 476 endoscopists citing it.

AI and automation in the medical endoscopy industry

  • 71.9% of 476 endoscopists considered financial reimbursement important for AI adoption in endoscopy in an intercontinental survey published in 2026.[1]
  • 39% of 465 endoscopists from 83 countries reported prior experience using AI in clinical practice in the World Endoscopy Organization survey conducted in 2024.[2]
  • 60% of 476 endoscopists reported prior exposure to AI in endoscopy in an intercontinental World Endoscopy Organization survey published in 2026, calculated from the reported 40% with no prior exposure.[1]

05 Statistics

Market Intelligence

Procedure-volume tracking provides cross-region scale, including 193.8 million endoscopy procedures estimated globally in 2025 and 33.7 million annually in the United States.

Market size and service revenue in the medical endoscopy industry

  • 193.8 million endoscopy procedures were estimated globally in 2025, covering diagnostic and therapeutic procedures across hospitals, ambulatory surgical centers and specialty clinics; the study reports procedure volume rather than provider revenue.[3]
  • 23,524,846 adult gastrointestinal endoscopy procedures were performed in the United States in 2022: 15,474,990 colonoscopies, 7,248,276 upper endoscopies and 801,588 other listed procedures; the study defines endoscopy using MarketScan claims data.[4]
  • 43,283,828 digestive endoscopic procedures were recorded in mainland China in 2023, including 12,428,502 diagnostic colonoscopies, 4,210,721 therapeutic colonoscopies and 2,944,035 therapeutic EGDs.[1]

Firm counts and size structure in the medical endoscopy industry

  • 6.7 endoscopists per hospital was the national average in mainland China in 2023, with 12.6 per tertiary general hospital and 3.7 per secondary general hospital.[1]
  • 5,738 mainland Chinese hospitals reported having gastroenterology departments or providing digestive endoscopy services in 2023; 4,620 hospitals were included in the analyzed National Clinical Improvement System sample.[1]
  • 2,078 Medicare-certified U.S. ambulatory surgical centers offered endoscopy surgery in 2025, according to a dataset covering endoscopy-specialized ASCs; this was 46.4% more than in 2017.[5]

Regional breakdown of the medical endoscopy industry

  • The United States accounted for 33.7 million annual endoscopy procedures, including gastrointestinal and non-gastrointestinal procedures, in the source’s major-market dataset.[6]
  • Germany accounted for 7.5 million annual endoscopy procedures in the source’s major-market dataset.[6]
  • Mainland China recorded 43,283,828 digestive endoscopic procedures in 2023, including diagnostic and therapeutic procedures across tertiary and secondary hospitals.[1]
  • The United Kingdom accounted for 4.8 million annual endoscopy procedures in the source’s major-market dataset.[6]

06 Statistics

Strategy & Growth

Deal activity points to consolidation in endoscopy delivery, including 11 U.S. gastroenterology physician-practice M&A deals in 2024.

M&A and consolidation in the medical endoscopy industry

  • 11 U.S. gastroenterology physician-practice M&A deals were recorded in 2024, down from 19 in 2023 and 27 in 2022; the category includes practices delivering endoscopy services, and the 2024 count includes one pending transaction.[7]
  • 266 endoscopy centers were included among 1,169 clinical sites in U.S. gastroenterology practices acquired by private equity between 2013 and 2023.[8]
  • 114 U.S. outpatient gastroenterology practices were acquired by private-equity firms between 2013 and 2023, encompassing 1,169 clinical sites; the study population included practices and ambulatory endoscopy centers.[8]

07 Statistics

Operating Benchmarks

Quality and throughput indicators frame operational performance, including a 35% minimum adenoma detection rate target for qualifying colonoscopies in 2024.

Operating metrics used in the medical endoscopy industry

  • The average mainland Chinese endoscopist performed 1,189.4 endoscopy cases annually in 2023; averages ranged from 360.3 to 1,811.9 cases across provinces.[1]
  • The 2024 ACG/ASGE quality-indicator guideline sets a target cecal-intubation rate of at least 95% for colonoscopy services.[9]
  • The 2024 ACG/ASGE quality-indicator guideline sets a minimum adenoma detection rate of 35% for qualifying colonoscopies in patients aged 45 years or older.[9]
  • The adenoma detection rate during colonoscopy in mainland China was 26.9% in 2023, up from 19.3% in 2019; the measure covers hospitals reporting to the national quality system.[1]

08 Statistics

Delivery & Operations

Installed capacity is measured through room counts, including 1,062 endoscopy rooms reported across 334 NHS and independent-sector services in the UK in 2024.

Delivery capacity and installed base in the medical endoscopy industry

  • 7 dedicated recovery spaces per endoscopy service were reported at the UK census median in 2024, with an interquartile range of 3–14 spaces.[10]
  • 6 additional endoscopy rooms had been delivered through four mobile endoscopy units in Scotland by July 2024.[11]
  • 14,700 U.S. establishments were estimated to have endoscopy rooms in 2024, indicating the scale of the installed delivery base for endoscopy services.[12]
  • 1,062 endoscopy rooms were reported by 334 NHS and independent-sector services in the UK endoscopy-estate census, comprising 860 NHS rooms and 202 independent-sector rooms, in 2024.[10]

09 Statistics

People & Workforce

Workforce constraints show up as vacancy and training pipeline metrics, including 57% of surveyed endoscopy units reporting unfilled vacancies in a UK regional survey.

Employment and hiring in the medical endoscopy industry

  • 57% of surveyed endoscopy units reported unfilled vacancies in a UK regional endoscopy workforce survey; no newer measurement of this specific metric was identified.[13]
  • 21% was the gastroenterology physician vacancy rate across U.S. Veterans Health Administration facilities in the 2023–24 national GI and hepatology services survey.[14]
  • 16.5% was the vacancy rate for UK endoscopy nurses in Band 5 positions in the 2023 UK-wide endoscopy workforce survey; no newer endoscopy-specific vacancy rate was identified.[10]

Skills and certification in the medical endoscopy industry

  • 5,256 trainees had been certified on the JETS endoscopy training system by 2024, including 2,787 in OGD, 2,033 in colonoscopy, 423 in flexible sigmoidoscopy, 11 in ERCP and 2 in EUS.[15]
  • 3,037 trainees submitted procedures through the JETS endoscopy training system in 2024.[15]
  • 620 trainees were certified on JETS in 2024, comprising 317 OGD, 285 colonoscopy, 5 flexible sigmoidoscopy, 11 ERCP and 2 EUS certifications.[15]

10 Statistics

Pricing

Pricing analysis ties economics to procedure mix, including a $434.75 average commercial professional reimbursement for CPT 43239 in New Jersey during June–July 2026.

Fees and price levels in the medical endoscopy industry

  • $434.75 was the average commercial professional reimbursement per upper-GI endoscopy with biopsy (CPT 43239) in New Jersey during June–July 2026, across Aetna, Anthem, Cigna and United rates.[16]
  • $950 was the facility fee for a combined EGD and colonoscopy at Arrowhead Endoscopy Center for self-pay patients, excluding physician, anesthesia and pathology fees.[17]
  • $2,703 was the average Medicare-and-patient payment per level-3 colonoscopy and lower-endoscopy procedure in 2024 across 923 U.S. hospitals.[18]

11 Statistics

Finance

Facility profitability benchmarks show outpatient endoscopy under ASC margins, including a 24.1% estimated EBITDA margin for U.S. ambulatory surgery centers in 2024.

Margins and profitability in the medical endoscopy industry

  • 24.1% was the estimated EBITDA margin for U.S. ambulatory surgery centers in 2024, the parent facility category containing outpatient endoscopy centers.[19]
  • 29.52% was the FY2024 operating margin for Pennsylvania ambulatory surgery centers, the parent facility category containing outpatient endoscopy centers.[20]
  • 28.13% was the FY2024 operating and total margin reported for UPMC Digestive Health Endoscopy, a named Pennsylvania endoscopy center.[20]

Ownership and investment in the medical endoscopy industry

  • 5% of analyzed gastroenterology practice transactions involved hospital systems, indicating that private-practice and private-equity buyers accounted for the remaining transactions in the study dataset.[21]
  • 89% of analyzed gastroenterology practice transactions were partially backed by private equity, covering 106 transactions in the study dataset.[21]
  • 6.5% of U.S. physicians worked in wholly or jointly private-equity-owned practices in 2024, compared with 4.5% in 2022; gastroenterology is one of the specialties covered by the consolidation evidence.[22]

12 Statistics

Risk & Compliance

Safety outcomes are quantified through complication rates, including 5.15 gastrointestinal perforations per 10,000 colonoscopies globally in the updated meta-analysis.

Incidents, safety and loss events in the medical endoscopy industry

  • 7,875 patient complications were reported in U.S. FDA MAUDE records for EUS devices from January 2000 through August 2025.[1]
  • 5.15 gastrointestinal perforations occurred per 10,000 colonoscopies globally in an updated meta-analysis of 82 population-based studies covering 38.5 million procedures through December 2024.[23]
  • 18.39 gastrointestinal bleeding events occurred per 10,000 colonoscopies globally in an updated meta-analysis of 82 population-based studies covering 38.5 million procedures through December 2024.[23]

13 Statistics

Sustainability

Environmental impacts are measured by procedure type at two Japanese facilities, including 1,178 gCO2e per colonoscopy in June 2024–January 2025.

Energy, emissions and disclosure in the medical endoscopy industry

  • 949 gCO2e per esophagogastroduodenoscopy, 1,178 gCO2e per colonoscopy, 5,834 gCO2e per endoscopic submucosal dissection and 4,780 gCO2e per ERCP were estimated at two Japanese facilities during June 2024–January 2025.[1]
  • Patient travel generated 83.09% of greenhouse-gas emissions from gastrointestinal endoscopy, followed by electricity at 10.42%, medical-gas transport and use at 3.63%, and water consumption at 1.86% in a prospective tertiary-care assessment.[13]
  • 5.4–73.2 kgCO2e per gastrointestinal endoscopy procedure was reported across 28 environmental-impact studies; the review found heterogeneous methods and predominantly high-risk evidence, with no newer sector-wide standardized measurement identified.[1]

Key questions about the Medical Endoscopy Industry

What is the global medical endoscopy market size in 2026?
The global medical endoscopy market is estimated at $33.1 billion in 2026.
How fast is the medical endoscopy market expected to grow after 2026?
The forecast implies the global market will reach $61.5 billion by 2035. That corresponds to a 7.1% CAGR from 2026 to 2035.
Which companies lead the medical endoscopy industry?
Boston Scientific stands out for GI, urology and therapeutic endoscopy devices because it reported $2.916 billion in 2025 endoscopy sales, while HOYA focuses on PENTAX-branded medical endoscopes since it provides medical endoscopes under the PENTAX brand.
What do endoscopist surveys indicate about AI adoption drivers?
In a 2026 intercontinental survey, 71.9% of 476 endoscopists said financial reimbursement mattered for AI adoption in endoscopy. In 2024, 39% of 465 endoscopists from 83 countries reported prior experience using AI in clinical practice.
How concentrated is competition in medical endoscopy?
Top five share was 45% in 2025, with Olympus reported to have more than 15% share in 2025. Boston Scientific, Stryker, Olympus, Karl Storz and Medtronic collectively held 45% of the market.
What does the demand mix look like for U.S. procedures in 2022?
The U.S. had 23.5M endoscopy procedures in 2022, including 15.5M colonoscopies and 7.2M upper endoscopies.
Reference

Cite This Report

This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.

APA
Elena Vasquez. (2026, February 13). Medical Endoscopy Industry Statistics. Gitnux. https://gitnux.org/medical-endoscopy-industry-statistics
MLA
Elena Vasquez. "Medical Endoscopy Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/medical-endoscopy-industry-statistics.
Chicago
Elena Vasquez. 2026. "Medical Endoscopy Industry Statistics." Gitnux. https://gitnux.org/medical-endoscopy-industry-statistics.